Severe or persistent dizziness may indicate that your current dose is advancing faster than your body can tolerateslowing your dose escalation or staying at your current dose for an extra week often resolves the problem
Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: does inflammation play a role
Toni is quick to respond to my questions and gets things done
Basse, A
In another study in obese HFpEF patients, increased epicardial fat was associated with more marked hemodynamic changes: higher filling pressures, more severe pulmonary hypertension, and poorer functional capacity.35 In the EMPA-TROPISM25 clinical trial, a significant decrease in the total epicardial adipose tissue volume was seen after 6 months of empagliflozin treatment.30 This reduction was accompanied by an improvement in several inflammatory biomarkers, myocardial fibrosis, and aortic stiffness.30 Dapagliflozin, ipragliflozin, luseogliflozin, and canagliflozin, as well as some GLP-1 receptor agonists,34 have also led to reductions in epicardial adipose tissue, similar to the effects reported in EMPA-TROPISM
